Point Nine

What they fund

• Companies in AI for digital, physical, and biological domains [1].
• Early-stage companies, typically from pre-seed to Series C [1].
• Cheque sizes ranging from $1-10 million per company [1].
• Companies where founders can benefit from "unfair shortcuts" and accelerated learning [1].
• B2B software and SaaS companies with AI applications [1].

Investment thesis

Point Nine is a thesis-driven early-stage venture capital firm based in Europe, investing globally in AI for the digital, physical and biological world [1]. They focus on AI applications across these domains rather than a broad generalist mandate [1]. The firm operates as a small equal partnership, with each partner working closely with 6-8 companies [1]. They aim to work alongside exceptional founders to accelerate their learning, provide "unfair shortcuts," and help them realize their potential, indicating a hands-on, partnership-oriented approach [1].

Value add

Point Nine provides hands-on partnership, working closely with founders to accelerate learning and provide "unfair shortcuts" [1]. Each partner works with 6-8 companies, ensuring dedicated support [1].

Fit verdict: Ideal for AI-focused founders seeking a hands-on, partnership-oriented early-stage VC with a global reach.

Founder diligence script:

• How does Point Nine define "unfair shortcuts" in practice?
• What is the typical decision-making process for follow-on investments?
• How do partners balance their portfolio of 6-8 companies?
• What specific expertise do partners bring to AI in physical/biological domains?
• How does Point Nine measure success beyond financial returns?

Portfolio focus

• Attio: AI-native, highly customizable CRM for go-to-market teams [1].
• Clio: Global leader in legal software with AI-enabled platform [1].
• Docplanner: Global healthcare marketplace and SaaS platform [1].
• Loom: Leading async video messaging platform for work [1].
• Poolside: Frontier lab building foundation models and agents [1].

Notable investments & exits

• Loom: Acquired by Atlassian for close to $1B in 2023 [1].

Strategic implications

Point Nine's strict focus on AI across digital, physical, and biological domains positions it as a specialist in a high-growth, high-risk sector. This specialization allows for deep expertise and network effects within the AI community. The hands-on, partnership-oriented approach with a small team suggests a high-touch service model, which can be a significant differentiator for founders seeking active support. However, it may also limit the firm's capacity to scale its portfolio rapidly. The global investment mandate from a European base provides access to a diverse talent pool and market opportunities, but also requires robust operational capabilities to manage cross-border investments effectively.

Where they could go further

Point Nine could enhance its value proposition by developing more structured programs for portfolio companies, such as mentorship networks or industry-specific workshops, to complement its hands-on approach. Expanding its network of co-investors and strategic partners could provide additional resources and market access for portfolio companies, particularly in the physical and biological AI domains. Establishing a clearer framework for follow-on investments and reserve allocation would help manage portfolio growth and ensure sufficient capital for high-potential companies. Increasing transparency around fund size, vintage, and performance could attract more LPs and enhance the firm's credibility in the market.